{Reference Type}: Journal Article
{Title}: Analysis of the Expression and Prognostic Value of SIRTs in Hepatocellular Carcinoma.
{Author}: Qin C;Ye X;Luo H;Jin H;Liu Q;Li J;
{Journal}: Int J Gen Med
{Volume}: 17
{Issue}: 0
{Year}: 2024
{Factor}: 2.145
{DOI}: 10.2147/IJGM.S460549
{Abstract}: <B>UNASSIGNED: </B>This study contributes to the evolving understanding of the pivotal involvement of Sirtuins (SIRTs) in various human cancers, with a particular focus on elucidating their expression patterns and clinical relevance within the context of hepatocellular carcinoma (HCC). The investigation involves a comprehensive analysis of mRNA expression and prognostic implications associated with distinct SIRTs in HCC.<BR><B>UNASSIGNED: </B>Initial data pertaining to SIRT expression in HCC patients were collated from publicly accessible databases. Subsequently, the expression levels of select members of the SIRT family were validated using clinicopathological specimens from HCC patients. Additionally, HCC tissue microarray was employed to scrutinize the correlation between SIRT7 expression and HCC prognosis.<BR><B>UNASSIGNED: </B>The findings indicated a substantial upregulation of SIRT2, SIRT3, SIRT4, SIRT6, and SIRT7 in HCC tissues. Survival analysis underscored a pronounced association between elevated mRNA levels of SIRT3, SIRT6, and SIRT7 and an adverse prognosis for HCC patients. Particularly, SIRT7 emerged as a potential independent risk factor for poor prognosis in HCC patients. Examination of the HCC tissue microarray revealed heightened expression of SIRT7 in 68 cases (54.8%) of HCC tissues. Multivariate analysis established high SIRT7 expression as an independent risk factor for diminished Disease-Free Survival (DFS) and Overall Survival (OS) in HCC patients.<BR><B>UNASSIGNED: </B>The aberrant expression of SIRT7 presents itself may be as a novel biomarker for predicting the prognosis of HCC patients.